Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAF-mutations in non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands) - 1 Apr 2014

Brustugun Odd Terje, Khattak Asma Malik, Trømborg Anette Kjoshagen, Beigi Marzieh, Beiske Klaus, Lund-Iversen Marius, Helland Åslaug

Abstract excerpt

OBJECTIVES: Targeted therapies in non-small cell lung cancer (NSCLC) now also include inhibitors against mutated BRAF. We present clinicopathological characteristics of nearly one thousand unselected NSCLC patients tested for the targetable V600E/K BRAF-mutation. MATERIAL AND METHODS: NSCLC routinely tested for EGFR-mutations at Oslo University Hospital in the period February 2011-July 2013 were tested for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anaplastic Lymphoma Kinase
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Neoplasm Staging

Share to Proto-Oncogene Proteins B-raf

Share to Receptor Protein-Tyrosine Kinases

Share to Translocation, Genetic

Source

Identifiers

PMID: 24552757
DOI: 10.1016/j.lungcan.2014.01.023

Genes

BRAF
ALK
EGFR
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAF-mutations in non-small cell lung cancer.PMID 24552757Read ↗

Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.Semantic proximity Read ↗

Clinicopathological Features of Non-Small Cell Lung Carcinoma with BRAF Mutation.Semantic proximity Read ↗

A literature review of a meta-analysis of BRAF mutations in non-small cell lung cancer.Semantic proximity Read ↗

Targeting BRAF-Mutant Non-Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy.Semantic proximity Read ↗

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.Semantic proximity Read ↗

Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations.Semantic proximity Read ↗

A BRAF new world.Semantic proximity Read ↗

Biology and Clinical Management of Non-V600 BRAF Alterations in NSCLC.Semantic proximity Read ↗

Clinical characteristics and course of 63 patients with BRAF mutant lung cancers.Semantic proximity Read ↗

Targeting BRAF-mutant non-small cell lung cancer: Current status and future directions.Semantic proximity Read ↗

Pathways and targeting avenues of BRAF in non-small cell lung cancer.Semantic proximity Read ↗

EGFR, ALK, RET, KRAS and BRAF alterations in never-smokers with non-small cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.